Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl F Nathan

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2017
Rifamycin action on RNA polymerase in antibiotic-tolerant <i>Mycobacterium tuberculosis</i> results in differentially detectable populationsKohta Saito, Thulasi Warrier, Selin Somersan-Karakaya, et al.
Nature Communications|November 24, 2017
Structure of human immunoproteasome with a reversible and noncompetitive inhibitor that selectively inhibits activated lymphocytesRuda de Luna Almeida Santos, Lin Bai, Pradeep K Singh, et al.
Journal of Medicinal Chemistry|October 23, 2020
Structure-Activity Relationships of Noncovalent Immunoproteasome β5i-Selective DipeptidesWenhu Zhan, Pradeep K Singh, Yi Ban, et al.
The Journal of Antibiotics|March 24, 2019
Effect of C-2 substitution on the stability of non-traditional cephalosporins in mouse plasmaMatthew Zimmerman, Stacey L McDonald, Hsin-Pin Ho-Liang, et al.
ACS Infectious Diseases|January 6, 2026
Diaryl-Aminoindazole with Extensive In Vitro Mycobactericidal Activity Dependent on Exposure to Reactive Nitrogen SpeciesThulasi Warrier, María Martínez-Hoyos, Esther Porras De Francisco, et al.
ACS Medicinal Chemistry Letters|July 19, 2023
<i>Mycobacterium tuberculosis</i> PptT Inhibitors Based on Heterocyclic Replacements of AmidinoureasSamantha Ottavi, Kelin Li, Jackson G Cacioppo, et al.
Journal of Medicinal Chemistry|September 28, 2019
Selective Phenylimidazole-Based Inhibitors of the <i>Mycobacterium tuberculosis</i> ProteasomeWenhu Zhan, Hao-Chi Hsu, Trevor Morgan, et al.
Microbiology Spectrum|September 22, 2021
Characterization of Phosphopantetheinyl Hydrolase from Mycobacterium tuberculosisShilpika Pandey, Amrita Singh, Guangli Yang, et al.
Journal of Medicinal Chemistry|June 21, 2022
Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome InhibitorsHao Zhang, John Ginn, Wenhu Zhan, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2016
Brief treatment with a highly selective immunoproteasome inhibitor promotes long-term cardiac allograft acceptance in miceEsilida Sula Karreci, Hao Fan, Mayuko Uehara, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Proceedings of the National Academy of Sciences of the United States of America|June 1, 2017
Rifamycin action on RNA polymerase in antibiotic-tolerant <i>Mycobacterium tuberculosis</i> results in differentially detectable populationsKohta Saito, Thulasi Warrier, Selin Somersan-Karakaya, et al.
Nature Communications|November 24, 2017
Structure of human immunoproteasome with a reversible and noncompetitive inhibitor that selectively inhibits activated lymphocytesRuda de Luna Almeida Santos, Lin Bai, Pradeep K Singh, et al.
Journal of Medicinal Chemistry|October 23, 2020
Structure-Activity Relationships of Noncovalent Immunoproteasome β5i-Selective DipeptidesWenhu Zhan, Pradeep K Singh, Yi Ban, et al.
The Journal of Antibiotics|March 24, 2019
Effect of C-2 substitution on the stability of non-traditional cephalosporins in mouse plasmaMatthew Zimmerman, Stacey L McDonald, Hsin-Pin Ho-Liang, et al.
ACS Infectious Diseases|January 6, 2026
Diaryl-Aminoindazole with Extensive In Vitro Mycobactericidal Activity Dependent on Exposure to Reactive Nitrogen SpeciesThulasi Warrier, María Martínez-Hoyos, Esther Porras De Francisco, et al.
ACS Medicinal Chemistry Letters|July 19, 2023
<i>Mycobacterium tuberculosis</i> PptT Inhibitors Based on Heterocyclic Replacements of AmidinoureasSamantha Ottavi, Kelin Li, Jackson G Cacioppo, et al.
Journal of Medicinal Chemistry|September 28, 2019
Selective Phenylimidazole-Based Inhibitors of the <i>Mycobacterium tuberculosis</i> ProteasomeWenhu Zhan, Hao-Chi Hsu, Trevor Morgan, et al.
Microbiology Spectrum|September 22, 2021
Characterization of Phosphopantetheinyl Hydrolase from Mycobacterium tuberculosisShilpika Pandey, Amrita Singh, Guangli Yang, et al.
Journal of Medicinal Chemistry|June 21, 2022
Design, Synthesis, and Optimization of Macrocyclic Peptides as Species-Selective Antimalaria Proteasome InhibitorsHao Zhang, John Ginn, Wenhu Zhan, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 14, 2016
Brief treatment with a highly selective immunoproteasome inhibitor promotes long-term cardiac allograft acceptance in miceEsilida Sula Karreci, Hao Fan, Mayuko Uehara, et al.
Pageof 8